Table 2 Echocardiographic evaluation according to systemic embolism events

From: Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study

 

Embolism events N = 75

Non-embolism events N = 968

P-value

LVSDD, mm

35.3 ± 3.0

34.7 ± 4.2

0.147

LVEDD, mm

55.7 ± 8.8

56.4 ± 7.4

0.413

LVEF, %

39.7 ± 9.7

40.2 ± 9.7

0.682

LVEF ≤ 40%

39 (52.0%)

525 (54.2%)

0.720

LVT

11 (14.7%)

56 (5.8%)

0.006

LV wall motion

 Akinesis in apical segments

47 (62.7%)

390 (40.3%)

<0.001

 Hypokinesis in apical segments

23 (30.7%)

461 (47.6%)

0.038

 Global hypokinesis

5 (6.7%)

117 (12.1%)

0.159

LVA size, mm

38.7 ± 11.4

38.2 ± 11.2

0.731

  1. All statistical tests were two-sided at a significance level of 0.05.
  2. LVSDD left ventricular end systolic diameter, LVEDD left ventricular end-diastolic dimension, LVEF left ventricular ejection fraction, LV left ventricular, LVA left ventricular aneurysm, LVT left ventricular thrombus.
Back to article page